Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Microbial Pathogenesis|June 3, 2020
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Grasiele S V Tavares, et al.
Parasitology Research|October 19, 2021
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfectionNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Medical Microbiology and Immunology|April 19, 2021
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasisRafaella R Costa, João A Oliveira-da-Silva, Thiago A R Reis, et al.
Parasitology|November 28, 2024
Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Fabiana A G Maia, et al.
Microbial Pathogenesis|May 5, 2022
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasisDanniele L Vale, Amanda S Machado, Fernanda F Ramos, et al.
Parasite (Paris, France)|May 1, 2020
A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine modelGrasiele S V Tavares, Débora V C Mendonça, Isabela A G Pereira, et al.
Molecular Immunology|June 26, 2020
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasisJoão A Oliveira-da-Silva, Daniela P Lage, Fernanda F Ramos, et al.
Diagnostic Microbiology and Infectious Disease|May 8, 2024
A recombinant chimeric antigen constructed with B-cell epitopes from Mycobacterium leprae hypothetical proteins is effective for the diagnosis of leprosyBárbara P N Assis, Ana T Chaves, Daniela P Lage, et al.
Experimental Parasitology|December 30, 2021
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary studyDébora V C Mendonça, Grasiele S V Tavares, Isabela A G Pereira, et al.
Experimental Parasitology|July 6, 2020
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human diseaseAmanda S Machado, Fernanda F Ramos, Thaís T O Santos, et al.
Pageof 10